| ID: | 121 | |
|---|---|---|
| Name: | Compound 121 | |
| Description: | Original numeration in publication: 11d | |
| Labels: | Training_set, Benzylquinazoline | |
| CAS: | ||
| InChi Code: | InChI=1S/C32H27N5O5/c1-42-28-14-8-5-11-24(28)19-33-35-30(39)23-15-17-25(18-16-23)34-29(38)21-37-31(40)26-12-6-7-13-27(26)36(32(37)41)20-22-9-3-2-4-10-22/h2-19H,20-21H2,1H3,(H,34,38)(H,35,39)/b33-19+ |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 6.72 |
El-Adl, K.; El-Helby, A.-G. A.; Sakr, H. a. E.-H., S. S. A. Design, synthesis, molecular docking, and anticancer evaluations of 1-benzylquinazoline-2,4(1H,3H)-dione bearing different moieties as VEGFR-2 inhibitors. Arch. Pharm. (Weinheim) 2020, 353, e2000068. https://doi.org/10.1002/ardp.202000068 |
| 6.79626 |
Eq1: VEGFR-2 inhibition (Data used to train model) |